Table 1.
The clinical characteristics of PCOS patients and controls.
| Characteristic | Controls (N=30) | PCOS(N=27) | P value |
|---|---|---|---|
| Age (y) | 29.530 ± 3.441 | 27.190 ± 3.317 | 0.836 |
| BMI(kg/m2) | 19.358 ± 0.897 | 24.561 ± 2.790 | <0.0001**** |
| AMH (ng/mL) | 3.924 ± 1.984 | 13.467 ± 3.885 | 0.003** |
| Basal FSH (IU/L) | 6.757 ± 1.707 | 5.624 ± 1.638 | 0.872 |
| Basal LH (IU/L) | 5.092 ± 1.470 | 10.747 ± 5.306 | <0.0001**** |
| Basal LH/FSH | 0.776 ± 0.240 | 1.980 ± 0.930 | <0.0001**** |
| Basal E2 (ng/L) | 45.548 ± 15.901 | 46.589 ± 12.142 | 0.238 |
| Basal P (ng/L) | 0.231 ± 0.130 | 0.283 ± 0.133 | 0.960 |
| Basal T(ng/mL) | 0.205 ± 0.077 | 0.622 ± 0.351 | <0.0001*** |
| WBC(g/L) | 5.862 ± 0.872 | 7.348 ± 0.613 | 0.020* |
| Fasting blood glucose(mmol/L) | 4.957 ± 0.257 | 5.061 ± 0.359 | 0.004** |
| Fasting insulin(uU/m) | 7.537 ± 2.123 | 15.367 ± 10.400 | 0.0003*** |
| Cholesterol(mmol/L) | 4.716 ± 0.673 | 5.258 ± 0.9655 | 0.022* |
| Triglycerides(mmol/L) | 0.9601 ± 0.409 | 1.845 ± 0.972 | 0.001** |
| LDL(mmol/L) | 2.826 ± 0.516 | 3.195 ± 0.718 | 0.011* |
| HDL(mmol/L) | 1.614 ± 0.329 | 1.419 ± 0.307 | 0.591 |
P-values reported are the results of independent sample t-tests for dichotomous variables; x ± s; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. AMH, anti-Müllerian hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; P, progesterone; T, testosterone; LDL, low-density lipoprotein; HDL, high density lipoprotein.